Online Letters to the EditorThe authors replyLonghini, Federico MD; Pisani, Lara MD, PhD; Nava, Stefano MD, FERS; Navalesi, Paolo MD, FERSAuthor Information Intensive Care Unit, University Hospital Mater Domini, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy Department of Clinical, Integrated and Experimental Medicine, Respiratory and Critical Care Unit, S. Orsola-Malpighi Hospital, Alma Mater University, Bologna, Italy Intensive Care Unit, University Hospital Mater Domini, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy Dr. Pisani received funding from Chiesi and AIM ITALY SRL. Dr. Nava’s institution received funding from Fisher and Paykel. Dr. Navalesi’s institution received funding from Maquet Critical Care, Draeger, and Intersurgical S.p.A.; he received honoraria/speaking fees from Maquet Critical Care, Orionpharma, Philips, Resmed, Merck Sharp & Dome, and Novartis; and he disclosed that he contributed to the development of the helmet Next, whose license for patent belongs to Intersurgical S.P.A., and receives royalties for that invention. Dr. Longhini has disclosed that he does not have any potential conflicts of interest. Critical Care Medicine: January 2020 - Volume 48 - Issue 1 - p e76-e77 doi: 10.1097/CCM.0000000000004085 Buy Metrics Copyright © 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.